US Patent 11130746 Therapeutic compounds
Patent 11130746 was granted and assigned to C4X Discovery Limited on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+405 characters)
Article
Patent abstract
The present invention relates to compounds that are antagonists of the orexin-1 receptor. The compounds have the structural formula (I) defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
111307460
Date of Patent
September 28, 2021
0Patent Application Number
202004280
Date Filed
April 28, 2020
0Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
111307460
Date of Patent
September 28, 2021
0Patent Application Number
202004280
Date Filed
April 28, 2020
0Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11130746 Therapeutic compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11130746
Date of patent
September 28, 2021
Patent application number
20200428
Date Filed
April 28, 2020
Find more entities like US Patent 11130746 Therapeutic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
